Dr. Peter Small on Cough Science and the Impact of Acoustic Diagnostics

Transformation in Trials

Ever wondered about the science behind a simple cough? What if we told you that a cough is not as simple as it seems and AI technology could revolutionize how we perceive it? Come along as we host Dr. Peter Small, acoustic epidemiologist and Chief Medical Officer of Hyfe, who enlightens us on the complexity of measuring coughs in clinical trials. Hear how traditional cough assessment methods are falling short and the challenges the FDA faces when validating new cough-suppressing medications. Furthermore, we discuss the severe impact of chronic cough on individuals, exacerbated by the COVID-19 pandemic, and how acoustic AI offers a unobtrusive and privacy-preserving solution for cough counting.
Imagine a future where cough monitoring becomes as routine as step counting. In the second half of our chat, Peter shares insights on the potential of acoustic diagnostics in revolutionizing cough treatment. Hear about a promising digital therapeutic for chronic cough, designed to reduce cough frequency, and the scarcity of effective cough treatments in today's medical landscape. From wellness apps to dedicated watches and SDKs for various devices, we discuss different forms of cough recognition technology, setting the stage for a future where technology and healthcare converge in fascinating ways.
Guest:
Dr. Peter Small
Hyfe

________
Reach out to Sam Parnell and Ivanna Rosendal
Join the conversation on our LinkedIn page

Chapters

1. Dr. Peter Small on Cough Science and the Impact of Acoustic Diagnostics (00:00:00)

2. Managing Cough in Clinical Trials (00:00:21)

3. Cough Treatment and Acoustic Diagnostics (00:10:17)